CARNOVALE, VINCENZO
 Distribuzione geografica
Continente #
AS - Asia 1.725
NA - Nord America 1.247
EU - Europa 1.164
SA - Sud America 254
AF - Africa 50
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.446
Nazione #
US - Stati Uniti d'America 1.199
SG - Singapore 709
RU - Federazione Russa 503
VN - Vietnam 374
CN - Cina 328
IT - Italia 263
BR - Brasile 212
HK - Hong Kong 117
DE - Germania 76
FR - Francia 67
FI - Finlandia 51
NL - Olanda 50
GB - Regno Unito 35
JP - Giappone 33
BD - Bangladesh 23
CA - Canada 21
IN - India 21
KR - Corea 21
SE - Svezia 20
AR - Argentina 19
HU - Ungheria 18
MX - Messico 17
IE - Irlanda 13
ID - Indonesia 11
IQ - Iraq 11
ZA - Sudafrica 11
AT - Austria 10
CI - Costa d'Avorio 10
PH - Filippine 10
ES - Italia 9
TH - Thailandia 9
UA - Ucraina 9
EC - Ecuador 8
IL - Israele 8
PL - Polonia 8
CO - Colombia 7
MA - Marocco 7
PK - Pakistan 7
SK - Slovacchia (Repubblica Slovacca) 7
TR - Turchia 7
TW - Taiwan 7
UZ - Uzbekistan 7
LT - Lituania 6
BE - Belgio 5
KE - Kenya 5
AE - Emirati Arabi Uniti 4
PY - Paraguay 4
AU - Australia 3
BG - Bulgaria 3
DZ - Algeria 3
HR - Croazia 3
IR - Iran 3
NP - Nepal 3
SN - Senegal 3
TN - Tunisia 3
AO - Angola 2
AZ - Azerbaigian 2
BS - Bahamas 2
DO - Repubblica Dominicana 2
JO - Giordania 2
MT - Malta 2
SA - Arabia Saudita 2
TT - Trinidad e Tobago 2
VE - Venezuela 2
BH - Bahrain 1
BZ - Belize 1
CH - Svizzera 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DJ - Gibuti 1
EG - Egitto 1
ET - Etiopia 1
GH - Ghana 1
GT - Guatemala 1
GY - Guiana 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
ML - Mali 1
NC - Nuova Caledonia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SO - Somalia 1
Totale 4.446
Città #
Singapore 365
San Jose 202
Ashburn 138
Moscow 114
Hong Kong 110
Chandler 109
Beijing 100
Ho Chi Minh City 97
Hefei 86
Hanoi 85
Naples 71
Santa Clara 61
Napoli 55
Amsterdam 45
Los Angeles 38
The Dalles 37
Lauterbourg 36
Munich 36
Tokyo 30
Dong Ket 28
Turku 27
Council Bluffs 24
Millbury 19
Da Nang 18
Lawrence 17
Redondo Beach 17
Haiphong 16
Boston 15
Des Moines 15
Buffalo 14
Helsinki 14
New York 14
Seoul 13
Frankfurt am Main 12
Orem 12
Mexico City 10
Atlanta 9
Falkenstein 9
Poplar 9
São Paulo 9
Budapest 8
Fairfield 8
London 8
Rome 8
Washington 8
Bratislava 7
Brooklyn 7
Dallas 7
Dublin 7
Hải Dương 7
Jacksonville 7
Milan 7
Princeton 7
Seattle 7
Warsaw 7
Bến Tre 6
Johannesburg 6
Nanjing 6
Rio de Janeiro 6
Tashkent 6
Toronto 6
Wilmington 6
Baghdad 5
Belo Horizonte 5
Chennai 5
Dhaka 5
Lappeenranta 5
Montreal 5
Mugnano Di Napoli 5
Nairobi 5
Ninh Bình 5
Phoenix 5
Stockholm 5
Szeged 5
Tel Aviv 5
Vienna 5
Brussels 4
Charlotte 4
Guangzhou 4
Manchester 4
Quito 4
Salt Lake City 4
Shanghai 4
Ankara 3
Bangkok 3
Biên Hòa 3
Boardman 3
Brasília 3
Can Tho 3
Casablanca 3
Changsha 3
Chicago 3
Cotia 3
Dakar 3
Denver 3
Gödöllő 3
Jakarta 3
João Pessoa 3
Limatola 3
Manaus 3
Totale 2.437
Nome #
Olfactory performance in Cystic Fibrosis patients 183
Elexacaftor/Tezacaftor/Ivacaftor in Patients with Cystic Fibrosis Homozygous for the F508del Mutation and Advanced Lung Disease: A 48-Week Observational Study 179
Clinical expression of patients with the D1152H CFTR mutation 171
The role of nasal washes in CF patients affected by chronic rhinosinusitis 164
Cystic Fibrosis: the sense of smell. 155
Cystic Fibrosis: The Sense of Smell 152
Lung structure and function similarities between primary ciliary dyskinesia and mild cystic fibrosis: a pilot study 151
Extensive CFTR Gene Analysis Revealed a Higher Occurrence of Cystic Fibrosis Transmembrane Regulator-Related Disorders (CFTR-RD) among CF Carriers 142
Beneficial economic effect of a virtual model of care for cystic fibrosis 141
Inhalation therapy in cystic fibrosis 138
Adiponectin Expression Is Modulated by Long-Term Physical Activity in Adult Patients Affected by Cystic Fibrosis 135
The role of nasal washes in patients with Cystic Fibrosis affected by chronic rhinosinusitis 135
Clinical expression of cystic fibrosis in a large cohort of Italian siblings 133
Cystic Fibrosis in Adults: A Paradigm of Frailty Syndrome? An Observational Study 131
Lipidomic alterations in human saliva from cystic fibrosis patients 129
Supervised physical exercise improves clinical, anthropometric and biochemical parameters in adult cystic fibrosis patients: A 2-year evaluation 129
TAS2R38 is a novel modifier gene in patients with cystic fibrosis 126
Salivary cytokines and airways disease severity in patients with cystic fibrosis 120
Effectiveness and safety of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease with the Phe508del/minimal function genotype 117
A new method to improve the clinical evaluation of Cystic Fibrosis patients by mucus viscoelastic properties 115
Oxylipin profile in saliva from patients with cystic fibrosis reveals a balance between pro-resolving and pro-inflammatory molecules 115
Liver biochemical indexes and cholesterol metabolism in cystic fibrosis patients with F508del/CFTR variant genotype after elexacaftor/tezacaftor/ivacaftor treatment 114
Impaired Ratio of Unsaturated to Saturated Non-Esterified Fatty Acids in Saliva from Patients with Cystic Fibrosis 113
The impact of cystic fibrosis on the working life of patients: A systematic review 113
Metabolomic profiling of saliva from cystic fibrosis patients 107
Physical activity regulates tnfα and il-6 expression to counteract inflammation in cystic fibrosis patients 104
Clinical outcomes of digital health in adults with cystic fibrosis 98
Incidental late diagnosis of cystic fibrosis following AH1N1 influenza virus pneumonia: A case report 98
One year of treatment with elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis homozygous for the F508del mutation causes a significant increase in liver biochemical indexes 95
Effectivenesss of ivacaftor in severe cystic fibrosis patients and non-G551D gating mutations 95
Employment status and work ability in adults with cystic fibrosis 93
Anticholinergic burden and behavioral and psychological symptoms in older patients with cognitive impairment 91
Clinical outcomes of a large cohort of individuals with the F508del/5T;TG12 CFTR genotype 88
Influence of pancreatic status on circulating plasma sterols in patients with cystic fibrosis 83
Lumacaftor/ivacaftor improves liver cholesterol metabolism but does not influence hypocholesterolemia in patients with cystic fibrosis 76
Clinical outcome of individuals carrying 5T;TG12 in trans with CFTR variants with varying clinical consequences 69
Blood platelet reduction after elexacaftor/tezacaftor/ivacaftor treatment in people with cystic fibrosis may depend on systemic inflammation reduction 50
Effects of Oral Amino Acid Supplementation on Physical Activity, Systemic Inflammation, and Quality of Life in Adult Patients with Cystic Fibrosis: A Single-Center, Randomized, Double-Blind, Placebo-Controlled Pilot Study 43
Pulmonary Function Modulates Epigenetic Age in Subjects with Cystic Fibrosis 28
Case Series on the Combined Therapy with Elexacaftor/Tezacaftor/Ivacaftor During Pregnancy in Women with Severe Cystic Fibrosis: A Retrospective Report from an Italian Centre 23
Totale 4.542
Categoria #
all - tutte 13.092
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.092


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202130 0 0 0 0 0 0 0 0 0 0 2 28
2021/2022185 8 0 2 1 2 18 7 3 8 29 57 50
2022/2023274 25 21 15 13 34 31 5 22 53 38 12 5
2023/2024226 9 22 15 18 15 46 18 19 10 12 27 15
2024/20251.139 50 37 0 29 38 101 99 88 42 100 458 97
2025/20262.488 202 298 274 242 491 75 273 141 277 150 65 0
Totale 4.542